7Baggers
 cyclacel pharmaceuticals inc (cycc) institutional confidence  TradingKey Thu, 18 Jun 2026 05:19:17 GMT
 cyclacel pharmaceuticals inc  TradingKey Wed, 17 Jun 2026 21:18:45 GMT
 Penny Biotech Names Behind the Next Trial Watch  Kalkine Media Fri, 29 May 2026 07:00:00 GMT
 bgms - bio green med solution inc stock price and quote  Finviz Thu, 28 May 2026 07:03:50 GMT
 tradingkey  TradingKey Tue, 12 May 2026 09:50:25 GMT
 unusual volume - stock screener - news  Finviz Tue, 28 Apr 2026 10:42:06 GMT
 bio green med shifts to fire safety, says cash lasts into q3 2026  Stock Titan Mon, 30 Mar 2026 07:00:00 GMT
 cycc sec filings - bio green med solution inc 10-k, 10-q, 8-k forms  Stock Titan Fri, 13 Mar 2026 17:07:46 GMT
 cycc sec filings - cyclacel pharma 10-k, 10-q, 8-k forms  Stock Titan Fri, 13 Mar 2026 17:07:46 GMT
 cycc financials: income statement, balance sheet & cash flow  Stock Titan Tue, 03 Mar 2026 02:30:44 GMT
 cyclacel raises $3m in private placement  MSN Mon, 09 Feb 2026 04:44:52 GMT
 cyclacel raises $3m in private placement  MSN Sun, 08 Feb 2026 07:41:33 GMT
 published on: 2025-12-21 23:05:19  Улправда Sun, 21 Dec 2025 19:05:19 GMT
 stockwatch: wall street’s leaders and laggards of 2025  Genetic Engineering and Biotechnology News Sun, 21 Dec 2025 08:00:00 GMT
 published on: 2025-12-20 22:06:08  Улправда Sat, 20 Dec 2025 18:06:08 GMT
 published on: 2025-12-19 13:13:56  Улправда Fri, 19 Dec 2025 09:13:56 GMT
 published on: 2025-12-18 14:27:18  Улправда Thu, 18 Dec 2025 10:27:18 GMT
 cyclacel pharmaceuticals (bgms) stock chart and price history 2025  MarketBeat Mon, 24 Nov 2025 20:16:54 GMT
 Cyclacel Pharmaceuticals (BGMS) Stock Price, News & Analysis  MarketBeat Wed, 19 Nov 2025 10:40:56 GMT
 published on: 2025-11-16 16:56:09  newser.com Sun, 16 Nov 2025 22:56:09 GMT
 bio green med solution’s strategic shift and q3 results  TipRanks Fri, 14 Nov 2025 05:09:58 GMT
 bio green med solution’s strategic shift and q3 results  TipRanks Thu, 13 Nov 2025 08:00:00 GMT

Cyclacel Pharmaceuticals, Inc
(NASDAQ:CYCC) 

CYCC stock logo

Cyclacel Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer and other proliferative diseases. The company's oncology development programs include fadraciclib, a cyclin dependent kinase Inhibitors (CDK) that is in Phase I clinical trial f...

Founded: 1996
Full Time Employees: 12
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends